Product Images Tofidence
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Tofidence NDC 78206-201 by Organon Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 200 mg/10 mL Vial Carton - tofidence 03
                            
                                This text describes a medication named Tocilizumab-bavi, which comes in a 20 mg/mL solution for intravenous infusion in single-dose vials. The solution contains tocilizumab-bavi, arginine, histidine, polysorbate 80, sucrose, and other components. The recommended dosage and storage instructions are provided. Manufacturing information indicates that it is produced by Biogen MA Inc. in the USA.*
PRINCIPAL DISPLAY PANEL - 400 mg/20 mL Vial Carton - tofidence 04
                            
                                This is a description of a medication called "Tofidence" (tocilizumab-bavi) in the form of an injection solution. Each 1 ml of solution contains 20 mg of the active ingredient tocilizumab-bavi. The medication also includes other ingredients such as L-histidine hydrochloride, mannitol, polysorbate 80, sucrose, and water for injection. The recommended dosage and storage instructions are provided. The medication is manufactured by Sogen't and is available in a single-dose vial. It is for intravenous infusion use and should be protected from light and not frozen. Patients are required to receive the enclosed Medication Guide.*
PRINCIPAL DISPLAY PANEL - 80 mg/4 mL Vial Carton - tofidence 05
                            
                                This is a description for an injectable medication called tocilizumab-bavi, intended for intravenous infusion after dilution. It comes in a single-dose vial and should be refrigerated between 3°C to 8°C. The solution includes tocilizumab and arginine hydrochloride, among other components. The recommended dosage should be followed as per prescribing information. It is important to note that each patient is required to receive the enclosed Medication Guide with this product. The medication is manufactured by Bogen MA Inc in Cambridge, MA, USA, with a license number provided. The origin country is China.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.